Karen Shoos Lipton - Net Worth and Insider Trading
Karen Shoos Lipton Net Worth
The estimated net worth of Karen Shoos Lipton is at least $37,205 dollars as of 2024-09-19. Karen Shoos Lipton is the Director of Celldex Therapeutics Inc and owns about 889 shares of Celldex Therapeutics Inc (CLDX) stock worth over $37,205. Details can be seen in Karen Shoos Lipton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen Shoos Lipton has not made any transactions after 2013-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen Shoos Lipton
Karen Shoos Lipton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen Shoos Lipton owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of Karen Shoos Lipton’s form 4 insider trades.
Insider Ownership Summary of Karen Shoos Lipton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2013-12-06 | director |
Karen Shoos Lipton Latest Holdings Summary
Karen Shoos Lipton currently owns a total of 1 stock. Karen Shoos Lipton owns 889 shares of Celldex Therapeutics Inc (CLDX) as of December 6, 2013, with a value of $37,205.
Latest Holdings of Karen Shoos Lipton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2013-12-06 | 889 | 41.85 | 37,205 |
Holding Weightings of Karen Shoos Lipton
Karen Shoos Lipton Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen Shoos Lipton has made a total of 0 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years. The most-recent trade in Celldex Therapeutics Inc is the sale of 1,182 shares on December 6, 2013, which brought Karen Shoos Lipton around $434,336.
Insider Trading History of Karen Shoos Lipton
- 1
Karen Shoos Lipton Trading Performance
GuruFocus tracks the stock performance after each of Karen Shoos Lipton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen Shoos Lipton is 12%. GuruFocus also compares Karen Shoos Lipton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen Shoos Lipton within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Karen Shoos Lipton's insider trading performs compared to the benchmark.
Performance of Karen Shoos Lipton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.47 | | | | | |
| Relative Return to S&P 500(%) | 18.89 | | | | | |
Karen Shoos Lipton Ownership Network
Karen Shoos Lipton Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Karen Shoos Lipton is the director of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include SVP & Chief Product Dev Officer Elizabeth Crowley , SVP and CFO Samuel Bates Martin , and SVP & Chief Medical Officer Diane C. Young .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Karen Shoos Lipton made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,560 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Karen Shoos Lipton Mailing Address
Above is the net worth, insider trading, and ownership report for Karen Shoos Lipton. You might contact Karen Shoos Lipton via mailing address: 8101 Glenbrook Road, Bethesda Md 20814.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
